The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Acetaldehyde, Dopamine Hydrochloride, DHEA (Dehydroepiandrosterone), 7-Oxo-Dehydroepiandrosterone-3B-Acetate, Folliculinum, Oophorinum (Suis), Cholesterinum, Progesterone, Testosterone, Cortisone Aceticum, Aldosterone, Androsterone, Follicle Stimulating Hormone · ACETALDEHYDE 6 [hp_X]/mL; DOPAMINE HYDROCHLORIDE 6 [hp_X]/mL; 7-OXODEHYDROEPIANDROSTERONE 3-ACETATE 6 [hp_X]/mL; ESTRONE 8 [hp_X]/mL; SUS SCROFA OVARY 8 [hp_X]/mL; CHOLESTEROL 8 [hp_X]/mL; PROGESTERONE 8 [hp_X]/mL; TESTOSTERONE 8 [hp_X]/mL; CORTISONE ACETATE 12 [hp_X]/mL; ALDOSTERONE 12 [hp_C]/mL; ANDROSTERONE 12 [hp_C]/mL; FOLLITROPIN 12 [hp_C]/mL · Liquid · Oral · Dr. Donna Restivo DC
NDC 62185-0050-01 · 30 mL in 1 BOTTLE, DROPPER · UNAPPROVED HOMEOPATHIC · View full market →
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Medicare Part D does not cover homeopathic products, which are not FDA-approved drugs.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Not scored — fragility is computed for NADAC-priced NDCs.
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Dr. Donna Restivo DC | ACETALDEHYDE 6 [hp_X]/mL; DOPAMINE HYDROCHLORIDE 6 [hp_X]/mL; 7-OXODEHYDROEPIANDROSTERONE 3-ACETATE 6 [hp_X]/mL; ESTRONE 8 [hp_X]/mL; SUS SCROFA OVARY 8 [hp_X]/mL; CHOLESTEROL 8 [hp_X]/mL; PROGESTERONE 8 [hp_X]/mL; TESTOSTERONE 8 [hp_X]/mL; CORTISONE ACETATE 12 [hp_X]/mL; ALDOSTERONE 12 [hp_C]/mL; ANDROSTERONE 12 [hp_C]/mL; FOLLITROPIN 12 [hp_C]/mL | Aug 26, 2026 | Sep 2, 2026 |
| Dr. Donna Restivo DC | ACETALDEHYDE 6 [hp_X]/mL; DOPAMINE HYDROCHLORIDE 6 [hp_X]/mL; 7-OXODEHYDROEPIANDROSTERONE 3-ACETATE 12 [hp_C]/mL; ESTRONE 12 [hp_C]/mL; SUS SCROFA OVARY 8 [hp_X]/mL; CHOLESTEROL 12 [hp_X]/mL; PROGESTERONE 6 [hp_X]/mL; TESTOSTERONE 8 [hp_X]/mL; CORTISONE ACETATE 12 [hp_C]/mL; ALDOSTERONE 8 [hp_X]/mL; ANDROSTERONE 8 [hp_X]/mL; FOLLITROPIN 8 [hp_X]/mL | Jul 22, 2026 | Aug 19, 2026 |
| Dr. Donna Restivo DC | 7-OXODEHYDROEPIANDROSTERONE 3-ACETATE 6 [hp_X]/mL; ACETALDEHYDE 6 [hp_X]/mL; ALDOSTERONE 12 [hp_C]/mL; ANDROSTERONE 12 [hp_C]/mL; CHOLESTEROL 8 [hp_X]/mL; CORTISONE ACETATE 12 [hp_X]/mL; DOPAMINE HYDROCHLORIDE 6 [hp_X]/mL; ESTRONE 8 [hp_X]/mL; FOLLITROPIN 12 [hp_C]/mL; PROGESTERONE 8 [hp_X]/mL; SUS SCROFA OVARY 8 [hp_X]/mL; TESTOSTERONE 8 [hp_X]/mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Hormone Balance — NDC 62185-0050-01," retrieved September 3, 2026, https://drugdashboards.com/drug/62185005001.
Free to cite with attribution — see how the data is put together.